Cost-effectiveness of paramedic-administered prehospital thrombolysis for ST elevation myocardial infarction

OBJECTIVES: Guidelines recommend prehospital thrombolysis for ST-segment elevation myocardial infarction (STEMI) if trained clinicians can interpret 12-lead electrocardiogram (ECG) on site. The Queensland Ambulance Service (QAS) has a well-established prehospital reperfusion program under which all paramedics are trained in prehospital STEMI diagnosis on 12-lead ECG and administering thrombolysis in the field to eligible patients. Whilst the clinical benefits of this treatment are proven, its cost-effectiveness remains to be established. METHODS: We developed a decision-analytic microsimulation model to evaluate the cost-effectiveness of paramedic-administered thrombolysis for prehospital STEMI in the state of Queensland, Australia. The comparator was a hypothetical counterfactual group of patients who were clinically eligible for prehospital thrombolysis but received an alternate treatment pathway. The analysis was conducted from a health provider (Queensland Government) perspective. A lifetime time horizon was used. Input values of the acute phase were derived from our prehospital and linked hospital database of all STEMI patients receiving prehospital thrombolysis from QAS paramedics between January 2022 and December 2024. Input values of the long-term phase were obtained from published literature. Cost was expressed in Australian dollars (AUD) and United States dollars (USD) in 2026 value, and effectiveness in quality-adjusted life years (QALYs). RESULTS: Prehospital thrombolysis improved outcomes at a cost of AUD 16,750.22 per QALY gained (95% uncertainty range AUD 15,477.48 - 18,422.84) or USD 11,725.15 (USD 10,834.24 - 12,895.99). In the sensitivity analysis, the cost-effectiveness of prehospital thrombolysis was robust to changes in input values. CONCLUSIONS: Paramedic-administered thrombolysis in the field for prehospital STEMI, compared with no such treatment, represents value for money.

Authors

Institutions

Publication Details

Journal
Prehospital Emergency Care
Published
2026-11-16
DOI
https://doi.org/10.1080/10903127.2026.2764803
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cost-effectiveness of paramedic-administered prehospital thrombolysis for ST elevation myocardial infarction

Tan Nhut Doan, Claire Bertenshaw, Marcus Prior, Daniel Bodnar et al.
Prehospital Emergency Care
Acute Myocardial Infarction Research
article

Cost-effectiveness of paramedic-administered prehospital thrombolysis for ST elevation myocardial infarction

Tan Nhut Doan, Claire Bertenshaw, Marcus Prior, Daniel Bodnar, William Vollbon, Emma Bosley, Stephen Rashford
article en

Abstract

OBJECTIVES: Guidelines recommend prehospital thrombolysis for ST-segment elevation myocardial infarction (STEMI) if trained clinicians can interpret 12-lead electrocardiogram (ECG) on site. The Queensland Ambulance Service (QAS) has a well-established prehospital reperfusion program under which all paramedics are trained in prehospital STEMI diagnosis on 12-lead ECG and administering thrombolysis in the field to eligible patients. Whilst the clinical benefits of this treatment are proven, its cost-effectiveness remains to be established. METHODS: We developed a decision-analytic microsimulation model to evaluate the cost-effectiveness of paramedic-administered thrombolysis for prehospital STEMI in the state of Queensland, Australia. The comparator was a hypothetical counterfactual group of patients who were clinically eligible for prehospital thrombolysis but received an alternate treatment pathway. The analysis was conducted from a health provider (Queensland Government) perspective. A lifetime time horizon was used. Input values of the acute phase were derived from our prehospital and linked hospital database of all STEMI patients receiving prehospital thrombolysis from QAS paramedics between January 2022 and December 2024. Input values of the long-term phase were obtained from published literature. Cost was expressed in Australian dollars (AUD) and United States dollars (USD) in 2026 value, and effectiveness in quality-adjusted life years (QALYs). RESULTS: Prehospital thrombolysis improved outcomes at a cost of AUD 16,750.22 per QALY gained (95% uncertainty range AUD 15,477.48 - 18,422.84) or USD 11,725.15 (USD 10,834.24 - 12,895.99). In the sensitivity analysis, the cost-effectiveness of prehospital thrombolysis was robust to changes in input values. CONCLUSIONS: Paramedic-administered thrombolysis in the field for prehospital STEMI, compared with no such treatment, represents value for money.

Prehospital Emergency Care
Queensland Health (AU), Queensland University of Technology (AU), Royal Brisbane and Women's Hospital (AU), Queensland Ambulance Service (AU), Monash University (AU)
Good health and well-being
Acute Myocardial Infarction Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon